| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Artivion, Inc. (AORT) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. AORT is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 831.9K | $16.74M | - | |
| Other | 193.8K | $3.90M | - | |
| VP | 156.1K | $3.14M | - | |
| VP | 130.1K | $2.62M | - | |
| VP | 71.8K | $1.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 23, 2025 | Semedo Anthony B.50 | Director | Sell | 2,600 | $28.47 | $74,027.20 | -7.3% | +50.8% | -21.5% | |
| May 21, 2025 | Holloway Jean F49 | SVP, General Counsel | Sell | 9,926 | $29.00 | $287,854.00 | -5.0% | +47.2% | -20.2% | |
| May 9, 2025 | Stanton Marshall S. | SVP, Clinical &MD Affair | Sell | 10,548 | $29.13 | $307,265.35 | -4.7% | +13.1% | -12.1% | |
| Mar 11, 2025 | Holloway Jean F49 | SVP, General Counsel | Sale+OE | 18,020 | $23.61 | $425,509.86 | -8.4% | +24.3% | +54.8% | |
| Mar 11, 2025 | Davis John E | Chief Commercial Officer | Sale+OE | 15,100 | $23.61 | $356,548.75 | -6.7% | +24.3% | +54.8% | |
| Mar 6, 2025 | MacKin James P53 | President &CEO | Sale+OE | 88,439 | $24.77 | $2,190,848.33 | -4.9% | +16.0% | +49.9% | |
| Mar 6, 2025 | Horton Amy48 | VP, Chief Accounting Officer | Sell | 1,048 | $24.80 | $25,995.01 | -0.7% | +16.0% | +49.9% | |
| Mar 6, 2025 | Berry Lance A | Executive VP, CFO | Sell | 4,909 | $24.80 | $121,763.82 | -3.1% | +16.0% | +49.9% | |
| Mar 6, 2025 | Davis John E | Chief Commercial Officer | Sell | 2,618 | $24.80 | $64,938.70 | -1.2% | +16.0% | +49.9% | |
| Mar 6, 2025 | Stanton Marshall S. | SVP, Clinical &MD Affair | Sell | 1,603 | $24.80 | $39,761.13 | -1.4% | +16.0% | +49.9% |